{"id":378,"date":"2021-07-13T14:24:40","date_gmt":"2021-07-13T17:24:40","guid":{"rendered":"https:\/\/qrconsulting.com.br\/?p=378"},"modified":"2021-07-13T14:43:47","modified_gmt":"2021-07-13T17:43:47","slug":"medicamentos-sinteticos-novos-codigos-para-peticao","status":"publish","type":"post","link":"https:\/\/qrconsulting.com.br\/pt-br\/medicamentos-sinteticos-novos-codigos-para-peticao\/","title":{"rendered":"Medicamentos sint\u00e9ticos: novos c\u00f3digos para peti\u00e7\u00e3o"},"content":{"rendered":"

A Anvisa informa que os novos c\u00f3digos de assuntos para\u00a0peti\u00e7\u00e3o secund\u00e1ria de registro e p\u00f3s-registro de medicamentos sint\u00e9ticos j\u00e1 est\u00e3o dispon\u00edveis. Portanto, os\u00a0c\u00f3digos antigos ser\u00e3o exclu\u00eddos do sistema de peticionamento eletr\u00f4nico.<\/span>\u00a0<\/span><\/p>\n

Tamb\u00e9m j\u00e1 foram disponibilizados\u00a0os documentos do semin\u00e1rio virtual realizado em 5\/7 sobre o novo fluxo de publica\u00e7\u00e3o para medicamentos sint\u00e9ticos, inclusive o texto que re\u00fane as principais perguntas e respostas sobre o tema. Os materiais est\u00e3o reunidos\u00a0neste\u00a0<\/span>link<\/span>.\u00a0\u00c9 importante observar que as perguntas e respostas ser\u00e3o atualizadas periodicamente. O recebimento de contribui\u00e7\u00f5es pode ser realizado por meio de\u00a0<\/span>formul\u00e1rio espec\u00edfico<\/span>.\u00a0<\/span>\u00a0<\/span><\/p>\n

Confira abaixo as altera\u00e7\u00f5es:<\/span>\u202f<\/span><\/p>\n

 <\/p>\n

Registro:\u202f<\/span><\/p>\n

 <\/p>\n\n\n\n\n\n\n\n
\n

C\u00f3digos\u00a0antigos<\/span>\u202f\u202f<\/span>\u00a0<\/span><\/strong><\/b><\/p>\n<\/td>\n

\n

C\u00f3digos novos<\/strong><\/b>\u202f<\/span>\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11627\u202f\u202f\u202f GEN\u00c9RICO \u2013 Formul\u00e1rio de informa\u00e7\u00f5es relativas \u00e0 documenta\u00e7\u00e3o de registro (FIDR) ou Parecer de An\u00e1lise T\u00e9cnica da Empresa (Pate)\u202f<\/span>\u00a0<\/span><\/p>\n<\/td>\n

\n

12107\u202f\u202f\u202f GEN\u00c9RICO \u2013 Formul\u00e1rio de informa\u00e7\u00f5es relativas \u00e0 documenta\u00e7\u00e3o de registro (FIDR) \u2013 An\u00e1lise de Qualidade Registro\u202f<\/span>\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11626\u202f\u202f\u202f MEDICAMENTO INOVADOR \u2013 Formul\u00e1rio de informa\u00e7\u00f5es relativas \u00e0 documenta\u00e7\u00e3o de registro (FIDR) ou Parecer de An\u00e1lise T\u00e9cnica da Empresa (Pate)\u202f<\/span>\u00a0<\/span><\/p>\n<\/td>\n

\n

12108\u202f\u202f\u202f MEDICAMENTO INOVADOR \u2013 Formul\u00e1rio de informa\u00e7\u00f5es relativas \u00e0 documenta\u00e7\u00e3o de registro (FIDR) \u2013 An\u00e1lise de Qualidade Registro\u202f<\/span>\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11625\u202f\u202f\u202f MEDICAMENTO NOVO\u00a0\u2013Formul\u00e1rio de informa\u00e7\u00f5es relativas \u00e0 documenta\u00e7\u00e3o de registro (FIDR) ou Parecer de An\u00e1lise T\u00e9cnica da Empresa (Pate)\u202f<\/span>\u00a0<\/span><\/p>\n<\/td>\n

\n

12109\u202f\u202f\u202f MEDICAMENTO NOVO \u2013 Formul\u00e1rio de informa\u00e7\u00f5es relativas \u00e0 documenta\u00e7\u00e3o de registro (FIDR) \u2013 An\u00e1lise de Qualidade Registro\u202f<\/span>\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11628\u202f\u202f\u202f SIMILAR \u2013 Formul\u00e1rio de informa\u00e7\u00f5es relativas \u00e0 documenta\u00e7\u00e3o de registro (FIDR) ou Parecer de An\u00e1lise T\u00e9cnica da Empresa (Pate)\u202f<\/span>\u00a0<\/span><\/p>\n<\/td>\n

\n

12110\u202f\u202f\u202f SIMILAR \u2013 Formul\u00e1rio de informa\u00e7\u00f5es relativas \u00e0 documenta\u00e7\u00e3o de registro (FIDR) \u2013 An\u00e1lise de Qualidade Registro\u202f<\/span>\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n


\nP\u00f3s-registro:\u202f<\/span><\/p>\n

 <\/p>\n\n\n\n\n\n\n\n
\n

C\u00f3digos\u00a0antigos\u202f\u202f<\/span><\/strong><\/b>\u00a0<\/span><\/p>\n<\/td>\n

\n

C\u00f3digos novos\u202f<\/span><\/strong><\/b>\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11627\u202f\u202f\u202f GEN\u00c9RICO \u2013 Formul\u00e1rio de informa\u00e7\u00f5es relativas \u00e0 documenta\u00e7\u00e3o de registro (FIDR) ou Parecer de An\u00e1lise T\u00e9cnica da Empresa (Pate)\u202f<\/span>\u00a0<\/span><\/p>\n<\/td>\n

\n

12111\u202f\u202f\u202f GEN\u00c9RICO \u2013 Parecer de An\u00e1lise T\u00e9cnica da Empresa (Pate) \u2013 An\u00e1lise de qualidade P\u00f3s-Registro\u202f<\/span>\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11626\u202f\u202f\u202f MEDICAMENTO INOVADOR \u2013 Formul\u00e1rio de informa\u00e7\u00f5es relativas \u00e0 documenta\u00e7\u00e3o de registro (FIDR) ou\u202fParecer de An\u00e1lise T\u00e9cnica da Empresa (Pate)\u202f<\/span>\u00a0<\/span><\/p>\n<\/td>\n

\n

12112\u202f\u202f\u202f MEDICAMENTO INOVADOR \u2013 Parecer de An\u00e1lise T\u00e9cnica da Empresa (Pate) \u2013 An\u00e1lise de qualidade P\u00f3s-Registro\u202f<\/span>\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11625\u202f\u202f\u202f MEDICAMENTO NOVO\u00a0\u2013\u00a0Formul\u00e1rio de informa\u00e7\u00f5es relativas \u00e0 documenta\u00e7\u00e3o de registro (FIDR) ou Parecer de An\u00e1lise T\u00e9cnica da Empresa (Pate)\u202f<\/span>\u00a0<\/span><\/p>\n<\/td>\n

\n

12113\u202f\u202f\u202f MEDICAMENTO NOVO \u2013 Parecer de An\u00e1lise T\u00e9cnica da Empresa (Pate) \u2013 An\u00e1lise de qualidade P\u00f3s-Registro\u202f<\/span>\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11628\u202f\u202f\u202f SIMILAR \u2013 Formul\u00e1rio de informa\u00e7\u00f5es relativas \u00e0 documenta\u00e7\u00e3o de registro (FIDR) ou Parecer de An\u00e1lise T\u00e9cnica da Empresa (Pate)\u202f<\/span>\u00a0<\/span><\/p>\n<\/td>\n

\n

12114\u202f\u202f\u202f SIMILAR \u2013 Parecer de An\u00e1lise T\u00e9cnica da Empresa (Pate) \u2013 An\u00e1lise de qualidade P\u00f3s-Registro\u202f<\/span>\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

Fonte: Medicamentos sint\u00e9ticos: novos c\u00f3digos para peti\u00e7\u00e3o \u2014 Portugu\u00eas (Brasil) (www.gov.br)<\/a><\/h4>\n","protected":false},"excerpt":{"rendered":"

Novos c\u00f3digos de assuntos para peti\u00e7\u00e3o secund\u00e1ria de registro e p\u00f3s-registro j\u00e1 est\u00e3o dispon\u00edveis, bem como materiais sobre o tema.<\/p>\n","protected":false},"author":4,"featured_media":379,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[9,11,10],"class_list":["post-378","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias","tag-anvisa","tag-medicamentos-sinteticos","tag-saude"],"_links":{"self":[{"href":"https:\/\/qrconsulting.com.br\/pt-br\/wp-json\/wp\/v2\/posts\/378","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/qrconsulting.com.br\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/qrconsulting.com.br\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/qrconsulting.com.br\/pt-br\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/qrconsulting.com.br\/pt-br\/wp-json\/wp\/v2\/comments?post=378"}],"version-history":[{"count":5,"href":"https:\/\/qrconsulting.com.br\/pt-br\/wp-json\/wp\/v2\/posts\/378\/revisions"}],"predecessor-version":[{"id":399,"href":"https:\/\/qrconsulting.com.br\/pt-br\/wp-json\/wp\/v2\/posts\/378\/revisions\/399"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/qrconsulting.com.br\/pt-br\/wp-json\/wp\/v2\/media\/379"}],"wp:attachment":[{"href":"https:\/\/qrconsulting.com.br\/pt-br\/wp-json\/wp\/v2\/media?parent=378"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/qrconsulting.com.br\/pt-br\/wp-json\/wp\/v2\/categories?post=378"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/qrconsulting.com.br\/pt-br\/wp-json\/wp\/v2\/tags?post=378"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}